The Complement Content of the Serum of Normal as Opposed to Tumour Bearing Mice
1969

Complement Levels in Mice with Tumors

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): F. Hartveit

Primary Institution: Gade Institute, Department of Pathology, University of Bergen, Norway

Hypothesis

The growth of a genetically incompatible tumor transplant is accompanied by a reduction in the serum complement level.

Conclusion

Mice with tumors showed significantly lower complement levels compared to non-tumor bearing mice.

Supporting Evidence

  • The complement levels in non-tumor bearing mice were similar, with a mean titre of 1:64.
  • Tumor-bearing mice showed lower complement titres, averaging at 1:4.
  • The drop in complement levels was consistent across different tumor types.

Takeaway

When mice have tumors, their blood has less of a special protein that helps fight infections compared to mice without tumors.

Methodology

Serum and ascitic fluid were collected from tumor-bearing and non-tumor-bearing mice, and complement factor C1 was titrated.

Limitations

The study did not explore the exact mechanisms behind the drop in complement levels.

Participant Demographics

Mice from a closed colony and F1 hybrids, approximately 6 months old.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication